Johnson & Johnson, Inc.

Paper Summary:

This paper is a stock analysis of Johnson & Johnson, Inc. and their efforts at reducing costs, increasing market share, meeting their shareholders and stakeholders as well as industry expectations while still fulfilling the very high levels of quality demanded by their customers. The author uses the Capital Asset Pricing Model, which takes into consideration the inherent risk that is associated with any investment and the rates of return, to determine that Johnson & Johnson's return on investment must be greater than a return of 6.07 percent. The paper concludes that, through new acquisitions, novel business strategies and a regular migration to cheaper labor pools, Johnson & Johnson Inc has become a strong force to be reckoned with in the highly competitive major drugs and healthcare industry; the author recommends a buy order at $60. Illustration. Charts. Tables.

Table of Content
Introduction
Economic and Market Analysis
Globalization
Industry Analysis
Company Analysis
Brief History of the Company
Analysis of Capital Asset Pricing Model
Intrinsic Value
Recommendation and Conclusion
Appendix A: Valuation Measures
Appendix B: Trading Information
Appendix C: Competitors
Appendix D: Awards & Recognition

From the Paper:

"The company has a long history of innovation and success. The founders created the first 'ready-made, ready-to-use surgical dressings' and initiated the way for 'application of the theory of antiseptic wound treatment' in the mid-1880's. These new products and services concepts literally reduced the threat of infection and disease in postoperative victims and helped save many lives in the early days of modern medicine. "The story begins with the discoveries of Sir Joseph Lister, a noted English surgeon, who identified airborne germs as a source of infection in the operating room. He called them, with grim aptness, the "invisible assassins." Medical science was beginning to understand, however imperfectly, the need for greater care in protecting the wound area."

More papers on Johnson & Johnson, Inc.:

• Comparison Essay # 72217 : "Johnson Controls, Inc. and Dana Corporation"
• Case Study # 118541 : "Success and Johnson and Johnson"

APA Citation:

MLA Citation: